Bringing the fundamentals into focus…
Back to NeuroPace, Inc.
How NeuroPace, Inc. stacks up
NPCE · against 421 other Healthcare companies of similar size
Profitability
24/ 100
Below the middle of the pack.
Ranked #303 of 422 · scores higher than 26% of peers
Bars: peers in each 10-point band of the profitability score53 peers with a profitability score of 20–29, including NPCE · Click a bar to see the companies
Why profitability scores 24?
Weighted metrics compared with all Healthcare companies.Mainly because of its return on assets, return on invested capital and operating margin, which are weaker than most Healthcare peers.
- a lower return on assets: weaker than 80% of peers. Return on assets: -19.7% vs peer median 1.7%
- a lower return on invested capital: weaker than 77% of peers. Return on invested capital: -16.4% vs peer median 4.7%
- a thinner operating margin: weaker than 76% of peers. Operating margin: -11.3% vs peer median 7.1%
Metric by metric
Position: dot = NPCE, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | NPCE | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 392 reported | -16.4% | 1.1% | 27% | 33% | |
| Operating marginHigher is better · 395 reported | -11.3% | 3.5% | 29% | 33% | |
| Return on assetsHigher is better · 421 reported | -19.7% | 0.5% | 23% | 33% | |
| Return on equityHigher is better · 401 reported | -103.3% | -0.0% | 7% | Context only | |
| Gross marginHigher is better · 441 reported | 77.4% | 39.4% | 88% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around NPCE| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 595M USD | 99 | 97 | |
| 1 | 433M USD | 99 | 81 | |
| 1 | 578M USD | 99 | 73 | |
| 1 | 609M USD | 99 | 91 | |
| 5 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 303 | 2.1B CNY (≈$291M) | 24 | 9 | |
| 303 | 775M USD | 24 | 31 | |
| 303 | 508M EUR (≈$559M) | 24 | 21 | |
| 303 | 598M USD | 24 | 49 | |
| 303 | 423M USD | 24 | 29 | |
| 303 | 513M USD | 24 | 31 | |
| 312 | 2.7B CNY (≈$381M) | 23 | 28 | |
| 312 | 7.1B TWD (≈$221M) | 23 | 25 | |
| 312 | 6.0B CNY (≈$841M) | 23 | 29 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score